Skip to content

Comparison of Auto-Adjusting Positive Airway Pressure Devices

Comparison of Auto-Adjusting Positive Airway Pressure Devices

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02357706
Enrollment
20
Registered
2015-02-06
Start date
2015-01-31
Completion date
2015-12-31
Last updated
2020-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Brief summary

Little is understood about how different auto-adjusting PAP devices operate. The purpose of this evaluation is to compare two devices in a randomised two night PSG trial.

Interventions

DEVICEAPAP A (ResMed AirSense AutoSet)

Commercially available device used to treat obstructive sleep apnea. The device automatically senses breathing and adjusts delivered pressure based on obstructive events

DEVICEAPAP B (Apex iCH Auto)

Commercially available device used to treat obstructive sleep apnea. The device automatically senses breathing and adjusts delivered pressure based on obstructive events

Sponsors

ResMed
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Males aged ≥ 18 years * Recently diagnosed with OSA (AHI ≥15). Recently defined as less than 3 months before study entry * Naive to CPAP therapy * Participants willing and able to give written informed consent

Exclusion criteria

* Participants requiring Bi-level PAP * Participants requiring supplemental oxygen * Participants who are pregnant * Subjects who have a pre existing lung disease/ condition that would predispose them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (\< 2years) case of pneumonia or lung infection; lung injury)

Design outcomes

Primary

MeasureTime frameDescription
Mean Apnoea-Hypopnoea-Index (AHI)1 night (446 minutes) for APAP A (AirSense), 1 night (436 minutes) for APAP B (Apex)AHI measures the number of apnoeas + hypopnoeas per hours of night (events/hour).
Mean Oxygen Desaturation Index (ODI)1 night (446 minutes) for APAP A, 1 night (436 minutes) for APAP B.Number of times that Oxygen Level Drops by 3% below baseline value, Events/hour

Secondary

MeasureTime frameDescription
Mixed Apnoea Index (MAI)1 night (446 minutes) for APAP A; 1 night (436 minutes) for APAP BNumber of obstructive and central apnoeas per hours of nights sleep, Events/hour
Hypopnoea-Index HI1 night (446 minutes) for APAP A; 1 night (436 minutes) for APAP BNumber of Hypopnoeas per hour of nights sleep, Events/hour
Obstructive Apnoea Index (OAI)1 night (446 minutes) for APAP A; 1 night (436 minutes) for APAP BNumber of obstructive apnoeas per hour of nights sleep, Events/hour
Flow Limitation (%)1 night (446 minutes) for APAP A; 1 night (436 minutes) for APAP BPercent of flow-limited breaths in relation to the overall breaths at night.
Mean O2 Saturation1 night (446 minutes) for APAP A; 1 night (436 minutes) for APAP BMean blood oxygen Saturation, %
Respiratory Effort Related Arousals RERAs1 night (446 minutes) for APAP A; 1 night (436 minutes) for APAP BNumber of RERAs per hour of nights sleep, Events/hour
Central Apnoea Index (CAI)1 night (446 minutes) for APAP A; 1 night (436 minutes) for APAP BNumber of central apnoeas during hours of sleep, events/hour

Countries

Germany

Participant flow

Participants by arm

ArmCount
All Study Participants
Patients will be randomised to either APAP A, then APAP B or APAP B, then APAP A. Patients in APAP A, then APAP B will use APAP A on the first night of the evaluation, and APAP B on the second night. Patients in APAP B, then APAP A will use APAP B on the first night of the evaluation and APAP A on the second night. APAP A (ResMed AirSense AutoSet): Commercially available device used to treat obstructive sleep apnea. The device automatically senses breathing and adjusts delivered pressure based on obstructive events APAP B (Apex iCH Auto): Commercially available device used to treat obstructive sleep apnea. The device automatically senses breathing and adjusts delivered pressure based on obstructive events
20
Total20

Baseline characteristics

CharacteristicAll Study Participants
Age, Continuous57.6 years
STANDARD_DEVIATION 12.5
Body Mass Index (BMI)31.1 kg/m2
STANDARD_DEVIATION 5.3
Neck Size41.1 cm
STANDARD_DEVIATION 3.6
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
20 Participants
Sex: Female, Male
Female
0 Participants
Sex: Female, Male
Male
20 Participants
waist-to-hip ratio1.01 ratio
STANDARD_DEVIATION 0.06

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 200 / 20
other
Total, other adverse events
0 / 200 / 20
serious
Total, serious adverse events
0 / 200 / 20

Outcome results

Primary

Mean Apnoea-Hypopnoea-Index (AHI)

AHI measures the number of apnoeas + hypopnoeas per hours of night (events/hour).

Time frame: 1 night (446 minutes) for APAP A (AirSense), 1 night (436 minutes) for APAP B (Apex)

Population: 20 patients have used APAP A, for which the primary outcome was calculated. The same 20 patients have used APAP B for which the Primary outcome was calculated.

ArmMeasureValue (MEAN)Dispersion
APAP A (AirSense Auto Set)Mean Apnoea-Hypopnoea-Index (AHI)6.21 events/hourStandard Deviation 6.73
APAP B (Apex iCH Auto)Mean Apnoea-Hypopnoea-Index (AHI)7.45 events/hourStandard Deviation 7.57
Comparison: Comparison of AHI/ oxygen desaturation index (ODI) of Device A compared with Device B.~Efficacy is defined as a residual AHI and ODI on each night of the trial. PSG scored AHI and ODI will be collected on both trial nights (excluding the ramp period); and compared using the Paired T testp-value: 0.537t-test, 1 sided
p-value: 0.05t-test, 1 sided
Primary

Mean Oxygen Desaturation Index (ODI)

Number of times that Oxygen Level Drops by 3% below baseline value, Events/hour

Time frame: 1 night (446 minutes) for APAP A, 1 night (436 minutes) for APAP B.

ArmMeasureValue (MEAN)Dispersion
APAP A (AirSense Auto Set)Mean Oxygen Desaturation Index (ODI)7.94 events/hourStandard Deviation 8.1
APAP B (Apex iCH Auto)Mean Oxygen Desaturation Index (ODI)10.63 events/hourStandard Deviation 9.5
p-value: 0.205t-test, 1 sided
p-value: 0.134t-test, 1 sided
Secondary

Central Apnoea Index (CAI)

Number of central apnoeas during hours of sleep, events/hour

Time frame: 1 night (446 minutes) for APAP A; 1 night (436 minutes) for APAP B

ArmMeasureValue (MEAN)Dispersion
APAP A (AirSense Auto Set)Central Apnoea Index (CAI)2.36 events/hourStandard Deviation 4.08
APAP B (Apex iCH Auto)Central Apnoea Index (CAI)2.51 events/hourStandard Deviation 5.14
Secondary

Flow Limitation (%)

Percent of flow-limited breaths in relation to the overall breaths at night.

Time frame: 1 night (446 minutes) for APAP A; 1 night (436 minutes) for APAP B

ArmMeasureValue (MEAN)Dispersion
APAP A (AirSense Auto Set)Flow Limitation (%)49.25 % overall breathsStandard Deviation 27.61
APAP B (Apex iCH Auto)Flow Limitation (%)43.16 % overall breathsStandard Deviation 22.59
Secondary

Hypopnoea-Index HI

Number of Hypopnoeas per hour of nights sleep, Events/hour

Time frame: 1 night (446 minutes) for APAP A; 1 night (436 minutes) for APAP B

ArmMeasureValue (MEAN)Dispersion
APAP A (AirSense Auto Set)Hypopnoea-Index HI3.17 events/hourStandard Deviation 3.8
APAP B (Apex iCH Auto)Hypopnoea-Index HI5.49 events/hourStandard Deviation 5.51
Secondary

Mean O2 Saturation

Mean blood oxygen Saturation, %

Time frame: 1 night (446 minutes) for APAP A; 1 night (436 minutes) for APAP B

ArmMeasureValue (MEAN)Dispersion
APAP A (AirSense Auto Set)Mean O2 Saturation94.210 % total hemoglobinStandard Deviation 2.414
APAP B (Apex iCH Auto)Mean O2 Saturation93.680 % total hemoglobinStandard Deviation 2.192
Secondary

Mixed Apnoea Index (MAI)

Number of obstructive and central apnoeas per hours of nights sleep, Events/hour

Time frame: 1 night (446 minutes) for APAP A; 1 night (436 minutes) for APAP B

ArmMeasureValue (MEAN)Dispersion
APAP A (AirSense Auto Set)Mixed Apnoea Index (MAI)0.115 events/hourStandard Deviation 0.514
APAP B (Apex iCH Auto)Mixed Apnoea Index (MAI)0.220 events/hourStandard Deviation 0.744
Secondary

Obstructive Apnoea Index (OAI)

Number of obstructive apnoeas per hour of nights sleep, Events/hour

Time frame: 1 night (446 minutes) for APAP A; 1 night (436 minutes) for APAP B

ArmMeasureValue (MEAN)Dispersion
APAP A (AirSense Auto Set)Obstructive Apnoea Index (OAI)0.580 events/hourStandard Deviation 1.525
APAP B (Apex iCH Auto)Obstructive Apnoea Index (OAI)0.885 events/hourStandard Deviation 1.668
Secondary

Respiratory Effort Related Arousals RERAs

Number of RERAs per hour of nights sleep, Events/hour

Time frame: 1 night (446 minutes) for APAP A; 1 night (436 minutes) for APAP B

ArmMeasureValue (MEAN)Dispersion
APAP A (AirSense Auto Set)Respiratory Effort Related Arousals RERAs0.0 events/hourStandard Deviation 0
APAP B (Apex iCH Auto)Respiratory Effort Related Arousals RERAs2.81 events/hourStandard Deviation 12.81

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026